Thomas Beetham - Chief Operating Officer at Viridian Therapeutics, Inc.\DE

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
VRDN on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Beetham since 9/17/2023

Holdings reported by Thomas Beetham for Viridian Therapeutics, Inc.\DE

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 474K Oct 30, 2023 Direct Common Stock

Transactions reported by Thomas Beetham for Viridian Therapeutics, Inc.\DE

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.